PulseAugur / Brief
EN
LIVE 22:03:24

Brief

last 24h
[2/2] 221 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. COMMENTARY · 36氪 (36Kr) 中文(ZH) ·

    Xingqi Pharmaceutical: Terminating Private Placement and Withdrawing Application Documents

    Xingqi Pharmaceutical has decided to terminate its private placement of A-shares, citing market conditions and its development plans. The company has withdrawn its application documents with the Shenzhen Stock Exchange, stating this decision will not significantly impact its operations. Separately, shareholders of Zhongxin Saike plan to reduce their holdings by up to 1.84% of the company's total share capital. AI

  2. MEME · 36氪 (36Kr) 中文(ZH) ·

    China-Singapore Sec: One of the controlling shareholders' concerted actors plans to reduce holdings of no more than 1.84% of the company's shares

    A shareholder group associated with Zhongxin Saike plans to reduce its stake in the company. Guangdong Hongtu Venture Capital, along with Nanjing Hongtu, Kunshan Hongtu, and Zhengzhou Bairui, intend to sell up to 1.84% of the company's shares. These entities are considered acting in concert with the company's controlling shareholder, Shenzhen Capital Group. AI